Associated Banc-Corp 8-K Summary
Business Context and Reporting Period
This Form 8-K Current Report, dated November 14, 2024, with a report date of November 18, 2024, concerns Associated Banc-Corp (ASB), a Wisconsin-based financial institution. The filing primarily addresses the completion of a material definitive agreement regarding a public equity offering.
Key Financial Metrics and Transaction Details
- Transaction Type: Underwritten public offering of common stock.
- Shares Issued: 13,800,000 shares of Common Stock ($0.01 par value).
- Offering Price: $25.00 per share.
- Over-Allotment: Underwriters exercised their option in full to purchase an additional 1,800,000 shares on November 15, 2024.
- Total Shares Sold: 15,600,000 shares (13,800,000 base + 1,800,000 option).
- Net Proceeds: Approximately $330.7 million after deducting underwriting discounts, commissions, and estimated offering expenses.
- Underwriters: BofA Securities, Inc. and J.P. Morgan Securities LLC.
Material Changes
The filing reports a significant increase in the company's equity capital base through the issuance of new common stock. The filing text does not provide comparative financial metrics (revenue, profit, cash flow, margins, or debt levels) for the current period versus prior periods, as this is a transaction-specific report rather than a periodic financial statement.
Outlook, Risks, and Management Commentary
The Company entered into an Underwriting Agreement containing customary representations, warranties, and covenants. Associated Banc-Corp agreed to indemnify the underwriters against certain liabilities under the Securities Act of 1933. The filing does not contain specific forward-looking guidance, risk factors, or management commentary beyond the details of the transaction execution.
Investor Verification Checklist
- Verify the final net proceeds of $330.7 million against the total shares issued (15.6 million) and the $25.00 offering price to confirm the effective underwriting discount and expense ratio.
- Review the attached Underwriting Agreement (Exhibit 1.1) for specific covenants and indemnification clauses.
- Confirm the impact of the 1,800,000 share over-allotment exercise on total dilution.
- Check subsequent filings for the intended use of the $330.7 million in net proceeds.